Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 3054252 | HLA-B (HLA-B) | keratoplasty | NA | NA | NA | unclassified | |
| 62 keratoplasty patients, 37 of whom had primarily poor prognoses and 25 patients with low risk of transplant rejection were prospectively given transplants in which more than two certain incompatibilities at the hla-a and hla-b locus had been ruled out. | |||||||
| 3054252 | HLA-A (HLA-A) | keratoplasty | NA | NA | NA | unclassified | |
| 62 keratoplasty patients, 37 of whom had primarily poor prognoses and 25 patients with low risk of transplant rejection were prospectively given transplants in which more than two certain incompatibilities at the hla-a and hla-b locus had been ruled out. | |||||||
| 3056548 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | only_studied | |
| the transfer of tetanus toxoid (tt) and diphtheria toxoid (dt) specific immunity was evaluated in 209 short-term (less than 120 days postgrafting) and 257 long-term (greater than 198 days postgrafting) non-boosted recipients after hla-identical, hla non-identical, and hla-identical t cell-depleted marrow transplantation. | |||||||
| 3056548 | HLA IDENTICAL (HLA-IDENTICAL) | tetanus | NA | NA | NA | only_studied | |
| the transfer of tetanus toxoid (tt) and diphtheria toxoid (dt) specific immunity was evaluated in 209 short-term (less than 120 days postgrafting) and 257 long-term (greater than 198 days postgrafting) non-boosted recipients after hla-identical, hla non-identical, and hla-identical t cell-depleted marrow transplantation. | |||||||
| 3056548 | HLA IDENTICAL (HLA-IDENTICAL) | diphtheria | NA | NA | NA | only_studied | |
| the transfer of tetanus toxoid (tt) and diphtheria toxoid (dt) specific immunity was evaluated in 209 short-term (less than 120 days postgrafting) and 257 long-term (greater than 198 days postgrafting) non-boosted recipients after hla-identical, hla non-identical, and hla-identical t cell-depleted marrow transplantation. | |||||||
| 3056548 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| these data show that transferred specific immunity is detectable in long-term recipients of t cell-depleted or hla-non-identical grafts without immunizations of donors or recipients before or after transplantation. | |||||||
| 3056552 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 3058105 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | methotrexate | NA | unclassified | |
| a prospective randomised trial of cyclosporin versus methotrexate after hla-identical sibling marrow transplantation for patients with acute leukemia in first remission: analysis 2.5 years after last patient entry. | |||||||
| 3058105 | HLA IDENTICAL (HLA-IDENTICAL) | leukemia | NA | methotrexate | NA | unclassified | |
| a prospective randomised trial of cyclosporin versus methotrexate after hla-identical sibling marrow transplantation for patients with acute leukemia in first remission: analysis 2.5 years after last patient entry. | |||||||
| 3058105 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | methotrexate | NA | unclassified | |
| the results of a prospective randomised trial comparing cyclosporin (csp) with methotrexate (mtx) as immunosuppressive therapy after hla-identical sibling marrow transplantation for patients with acute leukemia in first remission were analysed 2.5 years after entry of the last patient into the trial. | |||||||
Copyright 2024